Shearman & Sterling represented Itau BBA USA Securities, Bradesco Securities, J.P. Morgan Securities, Citigroup Global Markets, XP Investments US and BTG Pactual US Capital as international placement agents in connection with Blau Farmacêutica’s initial public offering of 27,299,078 common shares, without par value.

Brazilian pharmaceutical company Blau Farmacêutica’s specializes in biotechnological and synthetic products for oncology, nephrology, hematology and infectious diseases.

The Shearman & Sterling team below was supported by Marina Mendes Correa and Gabriela Laufer.

The Team